The European Commission has launched a three-month public consultation on a concept paper on the introduction of fees to be charged by the European Medicines Agency for new pharmacovigilance activities.
Go to Source

This entry was posted on Sunday, June 24th, 2012 at 11:30 pm and is filed under European Medicines Agency. You can follow any responses to this entry through the RSS 2.0 feed. You can skip to the end and leave a response. Pinging is currently not allowed.